Risk of macrosomia appeared higher in patients receiving glyburide than in those receiving insulin [RR, 2.48; 95%CI, 1.38 to 4.44; p = 0.002], with I2 decreasing from 66% to 30%. The gene discussed is INS; the disease is Large for gestational age.